Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04UNQ
|
|||
| Former ID |
DNC006932
|
|||
| Drug Name |
4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H10N6
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)N=NC2=C(NN=C2N)N
|
|||
| InChI |
1S/C9H10N6/c10-8-7(9(11)15-14-8)13-12-6-4-2-1-3-5-6/h1-5H,(H5,10,11,14,15)
|
|||
| InChIKey |
BLXRKDXUWQFGAW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 3656-02-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J Med Chem. 2006 Nov 2;49(22):6500-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.